OP
OPENZ
Opendoor Technologies Inc.
$0.2320
-3.33%
$223.4M
No data for this timeframe.
Vol
Market Cap$223.4M
Cap SizeMicro Cap
Inst. Holders5 funds
Inst. Value$430.0K
Inst. Activity2 buys / 0 sells
SEC Reports1
Recent Activity
Jun 2, 2026
SEC
Opendoor CEO Kaz Nejatian posted a message on X urging shareholders to vote for him at the upcoming Annual Meeting, afte
DEFA14A — Impact 4/10
Inst.
MORGAN STANLEY — NEW
895,907 shares ($357.8K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — NEW
150,123 shares ($60.0K)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $357.8K | NEW |
| RENAISSANCE TECHNOLOGIES LLC | $60.0K | NEW |
| BANK OF AMERICA CORP | $9.0K | — |
| NORGES BANK | $2.9K | — |
| WELLS FARGO & COMPANY/MN | $373.00 | — |
5 institutional holders with $430.0K total value (1,076,643 shares) as of 2025-Q4. Top holders: MORGAN, RENAISSANCE, BANK. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 895,907 | $357.8K | 83.2% | NEW |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 150,123 | $60.0K | 13.9% | NEW |
| 3 | BANK OF AMERICA CORP /DE/ | 22,467 | $9.0K | 2.1% | — |
| 4 | NORGES BANK | 7,213 | $2.9K | 0.7% | — |
| 5 | WELLS FARGO & COMPANY/MN | 933 | $373.00 | 0.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | NEW | — | 895,907 | — | $357.8K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 150,123 | — | $60.0K | 2025-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 4.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.9B | -42.5% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.1B | 23.2% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $3.9B | -10.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $6.7B | 72.8% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.